Transaction Case Studies

Development and Commercialization Agreement for Late-stage OTC Product

Situation Assessment

  • Strategic Science & Technologies, LLC (SST) is a drug delivery company that exploits a novel formulation and the chemical charges to drive active pharmaceutical ingredients across skin
  • Technology had near-term applications in a wide range of major therapeutic areas
  • Engaged Locust Walk Partners as its exclusive commercial and business development advisor.

Key Activities

  • Developed a comprehensive commercial assessment which included conducting primary market research among physicians, pharmacists and consumers. Instrumental in shifting partners perceptions of overall opportunity and for negotiating deal terms.
  • Led an outreach to a targeted list of leading global and regional companies active in the consumer healthcare arena.
  • Successfully secured competing term sheets from three of the largest consumer health care companies, with each company participating in a confidential diligence process.
  • Conducted face-to-face negotiations of the term sheet and definitive agreement.

Successful Outcome

  • Competitive negotiations process
  • Completed transaction with a leading healthcare / pharmaceutical company.

View press release »

Back to transactions »

Locust_Strategic

CLIENT: Strategic Science & Technologies, LLC

PARTNER: Undisclosed

TRANSACTION:
Worldwide Licensing Agreement for IbuCream (topical ibuprofen)